TheraPEG technology is used for the site-specific attachment of polyethylene glycol (PEG) polymer to therapeutic proteins. TheraPEG offers site-specific conjugation to disulfide bonds to achieve better product homogeneity
Following the acquisition, Aegera’s 20 plus employees will be joining Pharmascience’s team. The acquisition will allow Pharmascience to enhance its research and development activities through the continuance of
The dual site, two-cohort, open-label clinical trial is intended to assess the safety, bioactivity and anti tumor effect of infusion of patients’ own T cells that have been
The study aims to investigate the safety and tolerability of the treatment in progressive doses while assessing longer term efficacy measures for the design of future clinical trials
The rebranding of the firm is subject to approval of the Registrar of companies in India. Mylan expects to keep the Matrix name for the institutional ARV franchise,
NaAPR1M-74 is expected to be investigated as a potential vaccine candidate for human hookworm disease. The production is resulted from the collaboration between iBio’s research partner, the Fraunhofer
The 505(b)(2) filing of NDA was supported by the results from a Phase 3 FREEDOM-301 clinical trial which demonstrated that the patients who took Levadex, showed improvement at
Under the agreement, PAREXEL expects to achieve cost efficiencies in its clinical development program and leverage its clinical process along with its eClinical technology platform. The partnership model
The decision follows Sandoz’s submission of an abbreviated new drug application (ANDA) seeking marketing authorization of the generic version of AzaSite before expiration of the patents covering AzaSite
The survey showed that while many patients felt that a personalized targeted approach was not discussed, the majority of patients (62%) agreed that decisions about how to treat
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.